<Suppliers Price>

Leu-Leu

Names

[ CAS No. ]:
3303-31-9

[ Name ]:
Leu-Leu

[Synonym ]:
L-L
N-L-Leucyl-L-leucine
Leu-Leu
Leucine,leucyl
Leucylleucine
L-leucyl-L-leucine
L-Leu-L-Leu
L-leucine-L-leucine
H-Leu-Leu-OH

Biological Activity

[Description]:

Leu-Leu-OH is a human endogenous metabolite.

[Related Catalog]:

Research Areas >> Others

[Target]

Human Endogenous Metabolite

Chemical & Physical Properties

[ Density]:
1.051g/cm3

[ Boiling Point ]:
432.7ºC at 760mmHg

[ Molecular Formula ]:
C12H24N2O3

[ Molecular Weight ]:
244.33

[ Flash Point ]:
215.5ºC

[ Exact Mass ]:
244.17900

[ PSA ]:
92.42000

[ LogP ]:
2.06650

MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xi

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3.0

[ HS Code ]:
2924199090

Synthetic Route

Precursor & DownStream

Customs

[ HS Code ]: 2924199090

[ Summary ]:
2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Articles

Lovastatin and perillyl alcohol inhibit glioma cell invasion, migration, and proliferation--impact of Ras-/Rho-prenylation.

Pharmacol. Res. 91 , 69-77, (2015)

Alterations in small GTPase mediated signal transduction pathways have emerged as a central step in the molecular pathogenesis of glioblastoma (GBM), the most common malignant brain tumor in adults. F...

Aggregatibacter actinomycetemcomitans leukotoxin induces cytosol acidification in LFA-1 expressing immune cells.

Mol. Oral Microbiol. 31 , 106-14, (2016)

Studies have suggested that Aggregatibacter actinomycetemcomitans leukotoxin (LtxA) kills human lymphocyte function-associated antigen 1 (LFA-1; CD11a/CD18)-bearing immune cells through a lysosomal-me...

A novel compound, NK150460, exhibits selective antitumor activity against breast cancer cell lines through activation of aryl hydrocarbon receptor.

Mol. Cancer Ther. 14(2) , 343-54, (2015)

Antiestrogen agents are commonly used to treat patients with estrogen receptor (ER)-positive breast cancer. Tamoxifen has been the mainstay of endocrine treatment for patients with early and advanced ...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.